Literature DB >> 20610862

Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats.

K Kramkowski1, A Mogielnicki, A Leszczynska, W Buczko.   

Abstract

Angiotensin (Ang) (1-9) is the renin-angiotensin-system peptide found in the plasma of healthy volunteers and after angiotensin-converting-enzyme inhibitors therapy. In vitro experiments proved that Ang-(1-9) may be produced from Ang I. In our study, we tried to expand the poor data about the in vivo properties of Ang-(1-9). We revealed that Ang-(1-9) enhanced electrically stimulated arterial thrombosis in the carotid artery of Wistar rats. Losartan, a selective blocker of AT1 receptor for Ang II, abolished the prothrombotic activity of Ang-(1-9). This peptide increased plasma level of fibrinogen, augments fibrin generation, and similarly to Ang II, potentiated collagen induced platelet aggregation. Using HPLC, we found that after incubation of Ang-(1-9) with platelet homogenates or after intravenous administration this peptide is converted to Ang II. We concluded that Ang-(1-9) exerts an Ang II-like prothrombotic effect due to the conversion to Ang II in the circulatory system of rats and that platelets are involved in this process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610862

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  8 in total

Review 1.  The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.

Authors:  Ana Cristina Simões E Silva; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-09-23       Impact factor: 3.714

2.  Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7).

Authors:  Christian Meinert; Florian Gembardt; Ilka Böhme; Anja Tetzner; Thomas Wieland; Barry Greenberg; Thomas Walther
Journal:  J Proteomics       Date:  2015-09-24       Impact factor: 4.044

Review 3.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.

Authors:  María Paz Ocaranza; Jorge E Jalil
Journal:  Int J Hypertens       Date:  2012-01-19       Impact factor: 2.420

5.  Short-term treatment with nitrate is not sufficient to induce in vivo antithrombotic effects in rats and mice.

Authors:  K Kramkowski; A Leszczynska; K Przyborowski; B Proniewski; N Marcinczyk; U Rykaczewska; D Jarmoc; E Chabielska; S Chlopicki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-10-14       Impact factor: 3.000

6.  The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats.

Authors:  Bartlomiej Kalaska; Joanna Miklosz; Justyna Swieton; Aleksandra Jakimczuk; Dariusz Pawlak; Andrzej Mogielnicki
Journal:  Vaccine       Date:  2022-02-17       Impact factor: 4.169

7.  An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants.

Authors:  Shiho Tanaka; Gard Nelson; C Anders Olson; Oleksandr Buzko; Wendy Higashide; Annie Shin; Marcos Gonzalez; Justin Taft; Roosheel Patel; Sofija Buta; Ashley Richardson; Dusan Bogunovic; Patricia Spilman; Kayvan Niazi; Shahrooz Rabizadeh; Patrick Soon-Shiong
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

8.  Associations Between PFA-Measured Aspirin Resistance, Platelet Count, Renal Function, and Angiotensin Receptor Blockers.

Authors:  Hung Yi Chen; Pesus Chou
Journal:  Clin Appl Thromb Hemost       Date:  2018-07-11       Impact factor: 2.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.